VIVANI MEDICAL INC (VANI) Fundamental Analysis & Valuation

NASDAQ:VANI • US92854B1098

Current stock price

1.35 USD
+0.04 (+3.05%)
At close:
1.3501 USD
+0 (+0.01%)
After Hours:

This VANI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. VANI Profitability Analysis

1.1 Basic Checks

  • VANI had negative earnings in the past year.
  • VANI had a negative operating cash flow in the past year.
  • In the past 5 years VANI always reported negative net income.
  • In the past 5 years VANI always reported negative operating cash flow.
VANI Yearly Net Income VS EBIT VS OCF VS FCFVANI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -67.55%, VANI is doing worse than 74.33% of the companies in the same industry.
  • VANI has a worse Return On Equity (-169.16%) than 73.26% of its industry peers.
Industry RankSector Rank
ROA -67.55%
ROE -169.16%
ROIC N/A
ROA(3y)-46.17%
ROA(5y)-96.95%
ROE(3y)-95.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VANI Yearly ROA, ROE, ROICVANI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K -1K 2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VANI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VANI Yearly Profit, Operating, Gross MarginsVANI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. VANI Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for VANI has been increased compared to 1 year ago.
  • The number of shares outstanding for VANI has been increased compared to 5 years ago.
  • VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VANI Yearly Shares OutstandingVANI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VANI Yearly Total Debt VS Total AssetsVANI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -4.43, we must say that VANI is in the distress zone and has some risk of bankruptcy.
  • VANI has a Altman-Z score of -4.43. This is in the lower half of the industry: VANI underperforms 71.12% of its industry peers.
  • VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.43
ROIC/WACCN/A
WACCN/A
VANI Yearly LT Debt VS Equity VS FCFVANI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.71 indicates that VANI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.71, VANI is in line with its industry, outperforming 52.94% of the companies in the same industry.
  • VANI has a Quick Ratio of 2.71. This indicates that VANI is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.71, VANI perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 2.71
VANI Yearly Current Assets VS Current LiabilitesVANI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. VANI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.27% over the past year.
EPS 1Y (TTM)2.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -28.28% on average over the next years. This is quite bad
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y22.91%
EPS Next 2Y-6.71%
EPS Next 3Y-28.28%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VANI Yearly Revenue VS EstimatesVANI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2029 2030 2031 2032 2033 100M 200M 300M 400M
VANI Yearly EPS VS EstimatesVANI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. VANI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VANI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VANI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VANI Price Earnings VS Forward Price EarningsVANI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VANI Per share dataVANI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

  • VANI's earnings are expected to decrease with -28.28% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.71%
EPS Next 3Y-28.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VANI Dividend Analysis

5.1 Amount

  • No dividends for VANI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VANI Fundamentals: All Metrics, Ratios and Statistics

VIVANI MEDICAL INC

NASDAQ:VANI (4/24/2026, 8:12:55 PM)

After market: 1.3501 +0 (+0.01%)

1.35

+0.04 (+3.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-26
Earnings (Next)05-11
Inst Owners6.45%
Inst Owner Change1.26%
Ins Owners34.31%
Ins Owner Change0.21%
Market Cap114.28M
Revenue(TTM)N/A
Net Income(TTM)-26.61M
Analysts82.22
Price Target5.36 (297.04%)
Short Float %0.96%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.86%
Min EPS beat(2)1.96%
Max EPS beat(2)11.76%
EPS beat(4)2
Avg EPS beat(4)-1.66%
Min EPS beat(4)-17.65%
Max EPS beat(4)11.76%
EPS beat(8)6
Avg EPS beat(8)2.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5%
PT rev (3m)5%
EPS NQ rev (1m)11.11%
EPS NQ rev (3m)11.11%
EPS NY rev (1m)-2.44%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.26
P/tB 7.26
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -67.55%
ROE -169.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.17%
ROA(5y)-96.95%
ROE(3y)-95.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 139%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.71
Quick Ratio 2.71
Altman-Z -4.43
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)158.98%
Cap/Depr(5y)139.49%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
EPS Next Y22.91%
EPS Next 2Y-6.71%
EPS Next 3Y-28.28%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.57%
EBIT Next 3Y-15.98%
EBIT Next 5Y-39.03%
FCF growth 1Y13.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.29%
OCF growth 3YN/A
OCF growth 5YN/A

VIVANI MEDICAL INC / VANI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VIVANI MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to VANI.


What is the valuation status for VANI stock?

ChartMill assigns a valuation rating of 0 / 10 to VIVANI MEDICAL INC (VANI). This can be considered as Overvalued.


How profitable is VIVANI MEDICAL INC (VANI) stock?

VIVANI MEDICAL INC (VANI) has a profitability rating of 0 / 10.


Can you provide the financial health for VANI stock?

The financial health rating of VIVANI MEDICAL INC (VANI) is 6 / 10.


What is the expected EPS growth for VIVANI MEDICAL INC (VANI) stock?

The Earnings per Share (EPS) of VIVANI MEDICAL INC (VANI) is expected to grow by 22.91% in the next year.